[지배구조 리포트] 박재현 떠난 한미약품…이사회서 신동국 입김 줄이나

Hanmi Pharmaceutical has strengthened its board independence by appointing an independent director as board chair, reducing potential influence of its largest shareholder. This governance reform is significant as it enhances management transparency and shareholder protection, though the company still falls short of international ESG standards in areas like CEO succession planning and advance shareholder meeting notice.